BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21556051)

  • 1. Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth.
    Chen Z; Zhang C; Wu D; Chen H; Rorick A; Zhang X; Wang Q
    EMBO J; 2011 May; 30(12):2405-19. PubMed ID: 21556051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED1 mediates androgen receptor splice variant induced gene expression in the absence of ligand.
    Liu G; Sprenger C; Wu PJ; Sun S; Uo T; Haugk K; Epilepsia KS; Plymate S
    Oncotarget; 2015 Jan; 6(1):288-304. PubMed ID: 25481872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCI-779 inhibits cell-cycle G2-M progression and invasion of castration-resistant prostate cancer via attenuation of UBE2C transcription and mRNA stability.
    Wang H; Zhang C; Rorick A; Wu D; Chiu M; Thomas-Ahner J; Chen Z; Chen H; Clinton SK; Chan KK; Wang Q
    Cancer Res; 2011 Jul; 71(14):4866-76. PubMed ID: 21593191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcript Levels of Androgen Receptor Variant 7 and Ubiquitin-Conjugating Enzyme 2C in Hormone Sensitive Prostate Cancer and Castration-Resistant Prostate Cancer.
    Lee CH; Ku JY; Ha JM; Bae SS; Lee JZ; Kim CS; Ha HK
    Prostate; 2017 Jan; 77(1):60-71. PubMed ID: 27550197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK7 Inhibition Suppresses Castration-Resistant Prostate Cancer through MED1 Inactivation.
    Rasool RU; Natesan R; Deng Q; Aras S; Lal P; Sander Effron S; Mitchell-Velasquez E; Posimo JM; Carskadon S; Baca SC; Pomerantz MM; Siddiqui J; Schwartz LE; Lee DJ; Palanisamy N; Narla G; Den RB; Freedman ML; Brady DC; Asangani IA
    Cancer Discov; 2019 Nov; 9(11):1538-1555. PubMed ID: 31466944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity.
    Jin F; Irshad S; Yu W; Belakavadi M; Chekmareva M; Ittmann MM; Abate-Shen C; Fondell JD
    Mol Cancer Res; 2013 Jul; 11(7):736-47. PubMed ID: 23538858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer.
    Hu R; Lu C; Mostaghel EA; Yegnasubramanian S; Gurel M; Tannahill C; Edwards J; Isaacs WB; Nelson PS; Bluemn E; Plymate SR; Luo J
    Cancer Res; 2012 Jul; 72(14):3457-62. PubMed ID: 22710436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent androgen receptor-mediated transcription in castration-resistant prostate cancer under androgen-deprived conditions.
    Decker KF; Zheng D; He Y; Bowman T; Edwards JR; Jia L
    Nucleic Acids Res; 2012 Nov; 40(21):10765-79. PubMed ID: 23019221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.
    Hsieh CL; Fei T; Chen Y; Li T; Gao Y; Wang X; Sun T; Sweeney CJ; Lee GS; Chen S; Balk SP; Liu XS; Brown M; Kantoff PW
    Proc Natl Acad Sci U S A; 2014 May; 111(20):7319-24. PubMed ID: 24778216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen Receptor Interaction with Mediator Complex Is Enhanced in Castration-Resistant Prostate Cancer by CDK7 Phosphorylation of MED1.
    Russo JW; Nouri M; Balk SP
    Cancer Discov; 2019 Nov; 9(11):1490-1492. PubMed ID: 31676563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of cardiac Med1 inhibits RNA polymerase II promoter occupancy and promotes chromatin remodeling.
    Hall DD; Spitler KM; Grueter CE
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H314-H325. PubMed ID: 30461303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif.
    Jin F; Claessens F; Fondell JD
    J Biol Chem; 2012 Jan; 287(2):858-70. PubMed ID: 22102282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.
    Yang L; Lin C; Jin C; Yang JC; Tanasa B; Li W; Merkurjev D; Ohgi KA; Meng D; Zhang J; Evans CP; Rosenfeld MG
    Nature; 2013 Aug; 500(7464):598-602. PubMed ID: 23945587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic-induced repression of microRNA-205 is associated with MED1 activation and a poorer prognosis in localized prostate cancer.
    Hulf T; Sibbritt T; Wiklund ED; Patterson K; Song JZ; Stirzaker C; Qu W; Nair S; Horvath LG; Armstrong NJ; Kench JG; Sutherland RL; Clark SJ
    Oncogene; 2013 Jun; 32(23):2891-9. PubMed ID: 22869146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of P-TEFb by Androgen Receptor-Regulated Enhancer RNAs in Castration-Resistant Prostate Cancer.
    Zhao Y; Wang L; Ren S; Wang L; Blackburn PR; McNulty MS; Gao X; Qiao M; Vessella RL; Kohli M; Zhang J; Karnes RJ; Tindall DJ; Kim Y; MacLeod R; Ekker SC; Kang T; Sun Y; Huang H
    Cell Rep; 2016 Apr; 15(3):599-610. PubMed ID: 27068475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
    Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
    Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global analysis of transcription in castration-resistant prostate cancer cells uncovers active enhancers and direct androgen receptor targets.
    Toropainen S; Niskanen EA; Malinen M; Sutinen P; Kaikkonen MU; Palvimo JJ
    Sci Rep; 2016 Sep; 6():33510. PubMed ID: 27641228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 20. Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence.
    Sunkel B; Wu D; Chen Z; Wang CM; Liu X; Ye Z; Horning AM; Liu J; Mahalingam D; Lopez-Nicora H; Lin CL; Goodfellow PJ; Clinton SK; Jin VX; Chen CL; Huang TH; Wang Q
    Nucleic Acids Res; 2016 May; 44(9):4105-22. PubMed ID: 26743006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.